$144.95
0.98% yesterday
NYSE, May 20, 10:10 pm CET
ISIN
US46266C1053
Symbol
IQV

IQVIA Stock price

$144.95
+3.73 2.64% 1M
-49.43 25.43% 6M
-51.56 26.24% YTD
-85.14 37.00% 1Y
-56.88 28.18% 3Y
-0.47 0.32% 5Y
+76.14 110.65% 10Y
NYSE, Closing price Tue, May 20 2025
+1.41 0.98%
ISIN
US46266C1053
Symbol
IQV
Sector

Key metrics

Market capitalization $25.08b
Enterprise Value $37.72b
P/E (TTM) P/E ratio 19.75
EV/FCF (TTM) EV/FCF 17.44
EV/Sales (TTM) EV/Sales 2.43
P/S ratio (TTM) P/S ratio 1.62
P/B ratio (TTM) P/B ratio 4.22
Revenue growth (TTM) Revenue growth 2.84%
Revenue (TTM) Revenue $15.50b
EBIT (operating result TTM) EBIT $2.27b
Free Cash Flow (TTM) Free Cash Flow $2.16b
Cash position $1.88b
EPS (TTM) EPS $7.34
P/E forward 19.60
P/S forward 1.56
EV/Sales forward 2.35
Short interest 1.89%
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

20x Buy
74%
7x Hold
26%

Analyst Opinions

27 Analysts have issued a IQVIA forecast:

Buy
74%
Hold
26%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
15,496 15,496
3% 3%
100%
- Direct Costs 11,232 11,232
3% 3%
72%
4,264 4,264
3% 3%
28%
- Selling and Administrative Expenses 877 877
4% 4%
6%
- Research and Development Expense - -
-
-
3,387 3,387
5% 5%
22%
- Depreciation and Amortization 1,115 1,115
2% 2%
7%
EBIT (Operating Income) EBIT 2,272 2,272
9% 9%
15%
Net Profit 1,334 1,334
2% 2%
9%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Business Wire
5 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has announced a strategic collaboration with the contract research organization arm of Sarah Cannon Research Institute, SCRI Development Innovations, aimed at transforming oncolog...
Positive
Seeking Alpha
11 days ago
IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions segment, despite market pessimism. The company's profitability remains robust with adjusted EBITDA of $883M and a 6.3% increase in adjusted EPS, supported by high cash flow conversion. IQVIA's active share repurchase program and raised full-year revenue guidance highlight ...
Neutral
Business Wire
13 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Annual Health Care Conference on Tuesday, May 13, 2025, at 5:20 p.m. ET (2:20 p.m. local PT). A live audio webcast of the presentation will be available on the IQVIA Investor Relations ...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website www.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today